| Literature DB >> 35455628 |
Po-Chih Chang1,2,3,4, Kai-Hua Chen5, Hong-Jie Jhou6, Cho-Hao Lee7, Shah-Hwa Chou1,8, Po-Huang Chen9, Ting-Wei Chang5.
Abstract
OBJECTIVE: The chest tube drainage system (CTDS) of choice for the pleural cavity after pulmonary resection remains controversial. This systematic review and network meta-analysis (NMA) aimed to assess the length of hospital stay, chest tube placement duration, and prolonged air leak among different types of CTDS.Entities:
Keywords: chest tube drainage system; digital chest tube; lung resection; meta-analysis; network meta-analysis; pulmonary resection
Year: 2022 PMID: 35455628 PMCID: PMC9029690 DOI: 10.3390/jpm12040512
Source DB: PubMed Journal: J Pers Med ISSN: 2075-4426
Characteristics of enrolled studies.
| Author, Year | Patient Number | Gender (Male/ | Age (Mean ±SD) | Comorbidities (Number) | Surgical Indication | Surgical Approach | Size of Drain | Resection Type | Reported Incidence of Adverse Events (%) and Associated Items |
|---|---|---|---|---|---|---|---|---|---|
| Marshall | 68 | M: 49% | 63.4 ± 2.8 | NR | Benign and malignant lung tumors | NR | NR | NR | NR |
| Ayed | 100 | M: 94% | 23.0 ± 3.7 | Patients with underlying lung disease were excluded. | Primary spontaneous pneumothorax | VATS: 100% | 28 Fr. | Wedge resection: 100% | NR |
| Brunelli | 145 | M: 80.69% | 68.4 ± 9.2 | NR | Nonsmall cell carcinoma. | VATS: 0% | 28 Fr. | Lobectomy or bilobectomy: 100% | 24.83% |
| Alphonso 2005 [ | 254 | M: 61.51% | 57.5 ± NR | Previous pneumothorax(71) | NR | VATS: 42.26% | NR | Lobectomy: 46.44% | NR |
| Brunelli | 94 | M: 76.60% | 66.7 ± 10.1 | NR | Nonsmall cell carcinoma. | VATS: 0% | 28 Fr. | Bilobectomy: 9.57% | 24.47% |
| Kakhki | 31 | M: 70.97% | 36.8 ± 16.4 | NR | NR | VATS: 0% | NR | NR (excluding pneumonectomy or bronchoplasty) | NR |
| Cerfolio | 100 | M: 51% | 62.0 ± NR | NR | Nonsmall cell carcinoma. | VATS: 0% | NR | Lobectomy: 55% | NR |
| Prokakis | 91 | M: 63.74% | 59.5 ± 8.4 | NR | Lung malignancies. | VATS: 0% | 32 Fr. | Bilobectomy: 14.29% | 61.54% |
| Brunelli | 166 | M: 72.96% | 66.7 ± 10.9 | Co-morbidity index(mean, (SD)): 1.69(1.65) | Lung cancer. | VATS: 0% | 28 Fr. | Lobectomy: 100% | 15.06% |
| Filosso | 31 | M: 67.74% | 69.6 ± 3.4 | NR | Lung cancer. | VATS: 0% | 24 and 28 Fr. | Lobectomy: 100% | NR |
| Bertolaccini 2011 [ | 100 | M: 59% | 65.5 ± 13.6 | NR | NR | NR | 24 and 28 Fr. | Lobectomy: 48% | 2% |
| Marjański 2013 [ | 64 | M: 59.38% | 63.0 ± 21.5 | Htpertension (25) | Lung cancer. | VATS: 51.56% | 28 Fr. | Lobectomy: 100% | 37.50% |
| Brunelli | 100 | M: 70% | 67.3 ± 10.6 | Diabetes mellitus (13) | Lung cancer. | VATS: 0% | 28 Fr. | Lobectomy: 100% | 13% |
| Leo | 500 | M: 64.40% | 63.5 ± NR | Chronic obstructive lung disease (114) | NR | NR | 28 Fr. | NR | 45.8% |
| Pompili | 390 | M: 52.30% | 66.2 ± NR | NR | NR | VATS: 80.84% | 24 Fr. | Lobectomy: 85.30%% | NR |
| Gilbert | 176 | M: 36.36% | 68.0 ± NR | Co-morbidity index(mean):1 | Benign or neoplastic lung disease | VATS: 72.09% | NR | Lobectomy: 76.74% | 13.64% |
| Lijkendijk 2015 [ | 105 | M: 37.14% | 68.3 ± NR | NR | Lung cancer. | VATS: 39.04% | 24 Fr. | Lobectomy: 100% | NR |
| Gocyk | 254 | M: 62.20% | 60.3 ± NR | NR | Malignant, benign and metastatic lung tumors. | NR | NR | Lobectomy: 55.51% | 5.91% |
| Chiappetta 2017 [ | 95 | M: 51.58% | 63.6 ± 13.0 | Htpertension (45) | Benign or malignant lung disease | NR | 28 Fr. | Lobectomy: 52.63% | 2.11% |
| Plourde | 215 | M: 43.26% | 67.5 ± 9.3 | NR | Benign or malignant lung tumors | VATS: 83.72% | 28 Fr. | Lobectomy: 93.49% | 5.12% |
| Takamochi 2018 [ | 320 | M: 50.31% | 67.3 ± 11.7 | Diabetes mellitus (36) | Malignant, benign and metastatic lung tumors. | VATS: 0% | NR | Lobectomy: 79.26% | 21.25% |
F = female; M = male; NR = not recorded; SD = standard deviation; VATS = video-assisted thoracoscopic surgery; Fr. = French.
Figure 1PRISMA flow diagram of the study selection. Flow diagram for the identification process of eligible studies.
Figure 2Network structure of an outcome measure. The size of the nodes represents the number of objectives involved in the treatment approach. The numbers on the lines represent the number of comparisons between each treatment approach. (A) The length of hospital stay; (B) chest tube placement duration; (C) prolonged air leak.
Figure 3Network meta-analysis of (A) the length of hospital stay, (B) the chest tube placement duration, as well as (C) the prolonged air leak. The most beneficial intervention for the length of hospital stay was digital CTDS, which was 1.4 days shorter than the suction CTDSs (MD: −1.40; 95% CI: −2.20 to −0.60). Digital CTDS also significantly reduced chest tube placement duration by 0.68 days compared to suction CTDS (MD: −0.68; 95% CI: −1.32 to −0.04). Neither digital (OR: 0.76; 95% CI: 0.42–1.39) nor non-suction (OR: 0.95; 95% CI: 0.56–1.62) CTDS significantly reduced the risk of prolonged air leak. CI, confidence interval; MD, mean difference; OD, odds ratio.
Figure 4Rank-heat plot of P-score values among different chest tube drainage systems targeting the outcomes of length of hospital stay, chest tube placement duration, and prolonged air leak. Each slice of circle represents a different treatment. Treatments were ranked according to their P-score. A higher P-score (in green) denoted shorter hospital stay, shorter chest tube placement, and lower risk of prolonged air leak.